What does CUSIP 33938JAB2 represent in this 13F holders report?

CUSIP 33938JAB2 is the security identifier for 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 used to aggregate holder disclosures.

How many institutions held 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in Q1 2022?

No institutional holders were reported for 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in Q1 2022; review adjacent reporting periods for trend context.

FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Debt / NOTE 3.375% 5/0
Total 13F principal: $0
Principal change: -$84,194,000
Total reported market value: $0
Number of holders: 0
Value change: -$85,041,966
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2021

Recent filing periods for CUSIP 33938JAB2:

Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020

FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

Q1 2022 13F Holders as of 31 Mar 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q1 2022.